Suppr超能文献

利用噬菌体展示文库和兔抗丝状血凝素多克隆抗体对百日咳博德特氏菌丝状血凝素进行抗原分析。

Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.

作者信息

Wilson D R, Siebers A, Finlay B B

机构信息

Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Infect Immun. 1998 Oct;66(10):4884-94. doi: 10.1128/IAI.66.10.4884-4894.1998.

Abstract

Although substantial advancements have been made in the development of efficacious acellular vaccines against Bordetella pertussis, continued progress requires better understanding of the antigenic makeup of B. pertussis virulence factors, including filamentous hemagglutinin (FHA). To identify antigenic regions of FHA, phage display libraries constructed by using random fragments of the 10-kbp EcoRI fragment of B. pertussis fhaB were affinity selected with rabbit anti-FHA polyclonal antibodies. Characterization of antibody-reactive clones displaying FHA-derived peptides identified 14 antigenic regions, each containing one or more epitopes. A number of clones mapped within regions containing known or putative FHA adhesin domains and may be relevant for the generation of protective antibodies. The immunogenic potential of the phage-displayed peptides was assessed indirectly by comparing their recognition by antibodies elicited by sodium dodecyl sulfate (SDS)-denatured and native FHA and by measuring the inhibition of this recognition by purified FHA. FHA residues 1929 to 2019 may contain the most dominant linear epitope of FHA. Clones mapping to this region accounted for ca. 20% of clones recovered from the initial library selection and screening procedures. They are strongly recognized by sera against both SDS-denatured and native FHA, and this recognition is readily inhibited by purified FHA. Given also that this region includes a factor X homolog (J. Sandros and E. Tuomanen, Trends Microbiol. 1:192-196, 1993) and that the single FHA epitope (residues 2001 to 2015) was unequivocally defined in a comparable study by E. Leininger et al. (J. Infect. Dis. 175:1423-1431, 1997), peptides derived from residues of 1929 to 2019 of FHA are strong candidates for future protection studies.

摘要

尽管在开发有效的抗百日咳博德特氏菌无细胞疫苗方面已取得了重大进展,但要取得持续进展,需要更好地了解百日咳博德特氏菌毒力因子的抗原组成,包括丝状血凝素(FHA)。为了鉴定FHA的抗原区域,用百日咳博德特氏菌fhaB的10-kbp EcoRI片段的随机片段构建的噬菌体展示文库用兔抗FHA多克隆抗体进行亲和选择。对展示FHA衍生肽的抗体反应性克隆的表征鉴定出14个抗原区域,每个区域包含一个或多个表位。许多克隆定位在包含已知或推定的FHA粘附素结构域的区域内,可能与保护性抗体的产生有关。通过比较噬菌体展示肽被十二烷基硫酸钠(SDS)变性和天然FHA引发的抗体的识别情况,并通过测量纯化的FHA对这种识别的抑制作用,间接评估了噬菌体展示肽的免疫原性潜力。FHA的1929至2019位残基可能包含FHA最主要的线性表位。定位到该区域的克隆约占从初始文库选择和筛选程序中回收的克隆的20%。它们被抗SDS变性和天然FHA的血清强烈识别,并且这种识别很容易被纯化的FHA抑制。此外,鉴于该区域包括一个X因子同源物(J. Sandros和E. Tuomanen,《微生物学趋势》1:192 - 196,1993),并且E. Leininger等人在一项类似研究中明确界定了单个FHA表位(2001至2015位残基)(《传染病杂志》175:1423 - 1431,1997),来自FHA的1929至2019位残基的肽是未来保护性研究的有力候选物。

相似文献

5
Identification of immunodominant epitopes in the filamentous hemagglutinin of Bordetella pertussis.
FEMS Immunol Med Microbiol. 1999 Mar;23(3):235-41. doi: 10.1111/j.1574-695X.1999.tb01244.x.
8
Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
Clin Exp Immunol. 2006 Jun;144(3):543-51. doi: 10.1111/j.1365-2249.2006.03097.x.
10
Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines.
Infect Dis (Lond). 2016 Feb;48(2):127-32. doi: 10.3109/23744235.2015.1093655. Epub 2015 Oct 6.

引用本文的文献

3
Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.
Mol Biol Rep. 2011 Mar;38(3):1957-63. doi: 10.1007/s11033-010-0317-6. Epub 2010 Sep 28.

本文引用的文献

1
F1, A ROD-SHAPED MALE-SPECIFIC BACTERIOPHAGE THAT CONTAINS DNA.
Virology. 1963 Aug;20:638-40. doi: 10.1016/0042-6822(63)90290-3.
2
Phage Display.
Chem Rev. 1997 Apr 1;97(2):391-410. doi: 10.1021/cr960065d.
4
Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping.
J Bacteriol. 1997 Sep;179(18):5820-6. doi: 10.1128/jb.179.18.5820-5826.1997.
7
The multicenter acellular pertussis trial: an overview.
J Infect Dis. 1996 Nov;174 Suppl 3:S270-5. doi: 10.1093/infdis/174.supplement_3.s270.
8
Historical review of pertussis and the classical vaccine.
J Infect Dis. 1996 Nov;174 Suppl 3:S259-63. doi: 10.1093/infdis/174.supplement_3.s259.
9
Pertussis antigens that abrogate bacterial adherence and elicit immunity.
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 2):S145-9. doi: 10.1164/ajrccm/154.4_Pt_2.S145.
10
Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutinin.
Mol Microbiol. 1996 Jan;19(1):65-78. doi: 10.1046/j.1365-2958.1996.349883.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验